Notice Number: NOT-DA-20-050
Key Dates
Release Date: April 15, 2020
PAR-19-259
Issued by
National Institute on Drug Abuse (NIDA)
Purpose
The purpose of this notice is to inform interested applicants of a change to the Key Dates for PAR-19-259 "NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)".
Current Language
Part 1. Overview
Key Dates:
Application Due Date(s)
September 25, 2019; September 25, 2020; September 25, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
January 7, 2020; January 7, 2021; January 7, 2022 by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Scientific Merit Review
March 2020, March 2021, March 2022
Advisory Council Review
May 2020, May 2021, May 2022
Earliest Start Date
July 2020, July 2021, July 2022
Expiration Date
January 8, 2022
New Language
Part 1. Overview
Key Dates:
Application Due Date(s)
September 25, 2020; September 25, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
November 17, 2020 and November 17, 2021 by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Scientific Merit Review
March 2021, March 2022
Advisory Council Review
May 2021, May 2022
Earliest Start Date
July 2021, July 2022
Expiration Date
November 18, 2021
All other aspects of this FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Kevin Walton, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-0762
Email: [email protected]
Meyer D. Glantz, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-6504
Email: [email protected]
Roger Little, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-1316
Email: [email protected]
Steven Grant, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-4877
Email: [email protected]
and Human Services (HHS)
